ArticleCancer diagnosis & prognosis
Three-dimensional Conformal Radiation Planning Study for Limited-stage Small-cell Lung Cancer.
Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: To carry out a preliminary study to evaluate the dose distribution variation between the analytical anisotropic algorithm (AAA) and the Boltzmann transport equation, and between point and volume prescriptions in three-dimensional conformal radiation for limited-stage small-cell lung cancer. Patients and Methods: We retrospectively selected patients with limited-stage small-cell lung cancer who received radiotherapy alone or chemoradiotherapy. Gross tumor volume (GTV), clinical target volume (CTV), and planning target volume (PTV) were evaluated. Dose evaluation was performed for PTV, with AAA as point prescription, AAA as 50% prescription of PTV, Boltzmann transport equation as point prescription, and Boltzmann transport equation as 50% prescription of PTV. Results: A total of 22 patients (15 males, 7 females; mean age=63.4 years) were included. The mean radiation doses for AAA/point AAA/D50, Boltzmann transport/point, and Boltzmann transport/D50 methods were 99.97±1.5%, 102.1±1.2%, 100.8±1.2%, and 101.3±1.3% to the GTV; 98.4±2.1%, 100.4±0.5%, 99.6±1.9%, 100.1±1.0% to the CTV; and 96.7±2.5%, 97.4±4.6%, 97.6±2.3%, 98.3±0.8% to the PTV, respectively. For AAA/point, AAA/D50, Boltzmann transport/point, and Boltzmann transport/D50 prescription methods, the correlation between the GTV (102.5±107.8 ml) and mean dose to the GTV was 0.23 ( Conclusion: The AAA point-prescription approach can systematically underestimate target dose in 3D conformal radiotherapy for limited-stage small-cell lung cancer and shows less robust dose-volume behavior across GTV, CTV, and PTV compared with volume-based prescription and Boltzmann transport calculations. Therefore, AAA with point prescription should be avoided for dose calculation in this setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.